Krenger Werner, Holländer Georg A
Laboratory of Pediatric Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Best Pract Res Clin Haematol. 2008 Jun;21(2):119-28. doi: 10.1016/j.beha.2008.02.001.
A favorable outcome of allogeneic hematopoietic stem-cell transplantation (HSCT) depends on the complete reconstitution of the host's immune system. While recovery of peripheral T cells occurs in transplant recipients via both thymus-dependent and thymus-independent pathways, the regeneration of a population of phenotypically naive T cells with a broad T-cell receptor (TCR) repertoire relies entirely on the de novo generation of T cells in the thymus. However, preclinical models and clinical studies of allogeneic HSCT have identified the thymus as a target of graft-versus-host disease (GVHD). The present review focuses on recent insight into how GVHD affects thymic function and how this knowledge aides the design of new strategies to improve immune reconstitution following allogeneic HSCT.
异基因造血干细胞移植(HSCT)的良好预后取决于宿主免疫系统的完全重建。虽然移植受者外周T细胞的恢复通过胸腺依赖和非胸腺依赖途径发生,但具有广泛T细胞受体(TCR)库的表型幼稚T细胞群体的再生完全依赖于胸腺中T细胞的从头生成。然而,异基因HSCT的临床前模型和临床研究已将胸腺确定为移植物抗宿主病(GVHD)的靶标。本综述重点关注最近对GVHD如何影响胸腺功能的见解,以及这些知识如何有助于设计新策略以改善异基因HSCT后的免疫重建。